Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease

Clinical Microbiology Reviews

Volumn 19, Issue 1, 2006, Pages 80-94

  Fujinami, Robert S ^a   Von Herrath, Matthias G ^b   Christen, Urs ^b   Whitton, J Lindsay ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; AUTOIMMUNE DISEASE; BRAIN TISSUE; BYSTANDER EFFECT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE PREDISPOSITION; EPITOPE MAPPING; HEART; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; MOLECULAR MIMICRY; MOUSE; MULTIPLE SCLEROSIS; MYOCARDITIS; NONHUMAN; PANCREAS; PERSISTENT VIRUS INFECTION; REVIEW; VIRUS INFECTION;

ANIMALS; AUTOIMMUNE DISEASES; BYSTANDER EFFECT; FEMALE; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MOLECULAR MIMICRY; T-LYMPHOCYTES; VIRUS DISEASES; VIRUSES;

ANIMALIA;

EID: 31544479100     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.19.1.80-94.2006     Document Type: Review

References (161)

1. + T-cell responses against self- or non-self-antigens. Ann. N. Y. Acad. Sci. 987:99-106.
2. Alter, M., E. Kahana, and K. Loewenson. 1978. Migration and risk of multiple sclerosis. Neurology 28:1089-1093.
3. Alter, M., U. Leibowitz, and J. Speer. 1966. Risk of multiple sclerosis related to age at immigration to Israel. Arch. Neurol. 15:234-237.
4. Alter, M., and M. Okihiro. 1971. When is multiple sclerosis acquired? Neurology 21:1030-1036.
5. Alvord, E. C., Jr. 1984. Species-restricted encephalitogenic determinants, p. 523-537. In E. C. Alvord, Jr., M. W. Kies, and A. J. Suckling (ed.), Experimental allergic encephalomyelitis: a useful model for multiple sclerosis. Alan R. Liss, Inc., New York, N.Y.
6. Antel, J. 1999. Multiple sclerosis-emerging concepts of disease pathogenesis. J. Neuroimmunol. 98:45-48.
7. Archard, L. C., N. E. Bowles, L. Cunningham, C. A. Freeke, E. G. Olsen, M. L. Rose, B. Meany, H. J. Why, and P. J. Richardson. 1991. Molecular probes for detection of persisting enterovirus infection of human heart and their prognostic value. Eur. Heart J. 12(Suppl. D):56-59.
8. Archard, L. C., M. A. Khan, B. A. Soteriou, H. Zhang, H. J. Why, N. M. Robinson, and P. J. Richardson. 1998. Characterization of coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum. Pathol. 29:578-584.
9. Arif, S., T. I. Tree, T. P. Astill, J. M. Tremble, A. J. Bishop, C. M. Dayan, B. O. Roep, and M. Peakman. 2004. Autoreactive T-cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Investig. 113:451-463.
10. Barnett, L. A., J. L. Whitton, L. Y. Wang, and R. S. Fujinami. 1996. Virus encoding an encephalitogenic peptide protects mice from experimental allergic encephalomyelitis. J. Neuroimmunol. 64:163-173.
11. Bendig, J. W. A., P. S. O'Brien, P. Muir, H. J. Porter, and E. O. Caul. 2001. Enterovirus sequences resembling coxsackievirus A2 detected in stool and spleen from a girl with fatal myocarditis. J. Med. Virol. 64:482-486.
12. Bielekova, B., B. Goodwin, N. Richert, I. Cortese, T. Kondo, G. Afshar, B. Gran, J. Eatun, J. Antel, J. A. Frank, H. F. McFarland, and R. Martin. 2000. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6:1167-1175.
13. Bouman, A., M. J. Heineman, and M. M. Faas. 2005. Sex hormones and the immune response in humans. Hum. Reprod. Update 11:411-423.
14. Brehm, M. A., A. K. Pinto, K. A. Daniels, J. P. Schneck, R. M. Welsh, and L. K. Selin. 2002. T-cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627-634.
15. Brehm, M. A., L. K. Selin, and R. M. Welsh. 2004. CD8 T-cell responses to viral infections in sequence. Cell. Microbiol. 6:411-421.
16. Brode, S., and P. A. Macary. 2004. Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology 112:345-351.
17. Castano, L., and G. S. Eisenbarth. 1990. Type-I diabetes: a chronic auto-immune disease of human, mouse, and rat. Annu. Rev. Immunol. 8:647-679.
18. Christen, U., D. Benke, T. Wolfe, E. Rodrigo, A. Rhode, A. C. Hughes, M. B. A. Oldstone, and M. G. von Herrath. 2004. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Investig. 113:74-84.
19. Christen, U., K. H. Edelmann, D. B. McGavern, T. Wolfe, B. Coon, M. K. Teague, S. D. Miller, M. B. A. Oldstone, and M. G. von Herrath. 2004. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J. Clin. Investig. 114:1290-1298.
20. Christen, U., T. Wolfe, U. Mohrle, A. C. Hughes, E. Rodrigo, E. A. Green, R. A. Flavell, and M. G. von Herrath. 2001. A dual role for TNF-α in type I diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166:7023-7032.
21. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
22. Dalod, M., T. P. Salazar-Mather, L. Malmgaard, C. Lewis, C. Asselin-Paturel, F. Briere, G. Trinchieri, and C. A. Biron. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-528.
23. Dean, G., and J. K. Kurtzke. 1971. On the risk of multiple sclerosis according to age at immigration to South Africa. Br. Med. J. 3:725-729.
24. Donermeyer, D. L., K. W. Beisel, P. M. Allen, and S. C. Smith. 1995. Myocarditis-inducing epitope of myosin binds constitutively and stably to I-Ak on antigen-presenting cells in the heart. J. Exp. Med. 182:1291-1300.
25. Duke, R. C. 1989. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J. Exp. Med. 170:59-71.
26. Ebers, G. C., D. E. Bulman, A. D. Sadovnick, D. W. Paty, S. Warren, W. Hader. T. J. Murray, T. P. Seland, P. Duquette, T. Grey, R. Nelson, M. Nicolle, and D. Brunet. 1986. A population-based study of multiple sclerosis in twins. N. Engl. J. Med. 315:1638-1642.
27. Eremenko, T., A. Benedetto, and P. Volpe. 1972. Virus infection as a function of the host cell life cycle: replication of poliovirus RNA. J. Gen. Virol. 16:61-68.
28. + T helper cell and IL-2 independent in BALB/c mice. Am. J. Pathol. 127:335-341.
29. Fairfax, A. J., and U. Groschel-Stewart. 1977. Myosin autoantibodies detected by immunofluorescence. Clin. Exp. Immunol. 28:27-34.
30. Feuer, R., I. Mena, R. Pagarigan, M. K. Slifka, and J. L. Whitton. 2002. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76:4430-4440.
31. Feuer, R., I. Mena, R. R. Pagarigan, S. Harkins, D. K. Hassett, and J. L. Whitton. 2003. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons, and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 163:1379-1393.
32. Fujinami, R. S., and M. B. A. Oldstone. 1985. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230:1043-1045.
33. Fujinami, R. S., M. B. A. Oldstone, Z. Wroblewska, M. E. Fraukel, and H. Koprowski. 1983. Molecular mimicry in virus infection: Crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc. Natl. Acad. Sci. USA 80:2346-2350.
34. Fujinami, R. S., A. Zurbriggen, and H. C. Powell. 1988. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J. Neuroimmunol. 20:25-32.
35. Fujioka, S., Y. Kitaura, A. Ukimura, H. Deguchi, K. Kawamura, T. Isomura, H. Suma, and A. Shimizu. 2000. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 36:1920-1926.
36. Gauntt, C., and S. Huber. 2003. Coxsackievirus experimental heart diseases. Front. Biosci. 8:e23-e35.
37. Gebhard, J. R., C. M. Perry, S. Harkins, T. Lane, I. Mena, V. C. Asensio, I. L. Campbell, and J. L. Whitton. 1998. Coxsackievirus B3-incluccd myocarditis: perform exacerbates disease, but plays no detectable role in virus clearance. Am. J. Pathol. 153:417-428.
38. Gelfand, H. M. 1961. The occurrence in nature of the Coxsackie and ECHO viruses. Prog. Med. Virol. 3:193-244.
39. Gillum, R. F. 1986. Idiopathic cardiomyopathy in the United States. 1970-1982. Am. Heart J. 111:752-755.
40. Goodwin, J. F. 1992. Cardiomyopathies and specific heart muscle diseases. Definitions, terminology, classifications and new and old approaches. Postgrad. Med. J. 68(Suppl. 1):S3-S6.
41. Gravanis, M. B., and N. H. Sternby. 1991. Incidence of myocarditis. A 10-year autopsy study from Malmo, Sweden. Arch. Pathol. Lab. Med. 115: 390-392.
42. Greeley, S. A., M. Katsumata, L. Yu, G. S. Eisenbarth, D. J. Moore, H. Goodarzi, C. F. Barker, A. Naji, and H. Noorchashm. 2002. Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice. Nat. Med. 8:399-402.
43. Green, E. A., and R. A. Flavell. 2000. The temporal importance of TNFalpha expression in the development of diabetes. Immunity 12:459-469.
44. Grist, N. R., E. J. Bell, and F. Assaad. 1978. Enteroviruses in human disease. Prog. Med. Virol. 24:114-157.
45. Gronski, M. A., J. M. Boulter, D. Moskophidis, L. T. Nguyen, K. Holmberg, A. R. Elford, E. K. Deenick, H. O. Kim, J. M. Penninger, B. Odermatt, A. Gallimore, N. R. J. Gascoigne, and P. S. Ohashi. 2004. TCR affinity and negative regulation limit autoimmunity. Nat. Med. 10:1234-1239.
46. Guthrie, M., P. A. Lodge, and S. A. Huber. 1984. Cardiac injury in myocarditis induced by coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes. Cell. Immunol. 88:558-567.
47. Hamilton-Williams, E. E., A. Lang, D. Benke, G. M. Davey, K.-H. Wiesmüller, and C. Kurts. 2005. Cutting edge: TLR ligands are not sufficient to break cross-tolerance to self-antigens. J. Immunol. 174:1159-1163.
48. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:126-134.
49. Heck, C. F., S. J. Shumway, and M. P. Kaye. 1989. The Registry of the International Society for Heart Transplantation: sixth official report-1989. J. Heart Transplant. 8:271-276.
50. Heim, A., A. Canu, P. Kirschner, T. Simon, G. Mall, P. H. Hofschneider, and R. Kandolf. 1992. Synergistic interaction of interferon-β and interferon-γ in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J. Infect. Dis. 166:958-965.
51. Hemmer, B., B. T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K.-H. Wiesmüller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class H-restricted T-cell clone. J. Exp. Med. 185:1651-1659.
52. Hemmer, B., B. Gran, Y. Zhao, A. Marques, J. Pascal, A. Tzou, T. Kondo, I. Cortese, B. Bielekova, S. E. Straus, H. F. McFarland, R. Houghten, R. Simon, C. Pinilla, and R. Martin. 1999. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat. Med. 5:1375-1382.
53. + T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol. 69:6720-6728.
54. Horwitz, M. S., L. M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick. 1998. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781-785.
55. Huber, S. A. 2000. T cells expressing the gamma delta T-cell receptor induce apoptosis in cardiac myocytes. Cardiovasc. Res. 45:579-587.
56. + T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice. J. Immunol. 165:4174-4181.
57. Huber, S. A., and P. A. Lodge. 1984. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am. J. Pathol. 116:21-29.
58. Huber, S. A., D. C. Lyden, and P. A. Lodge. 1985. Immunopathogenesis of experimental Coxsackievirus induced myocarditis: role of autoimmunity. Herz 10:1-7.
59. + Th1 cells. J. Virol. 76:10785-10790.
60. Jacob, C. O., S. Aiso, S. A. Michie, H. O. McDevitt, and H. Acha-Orbea. 1990. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA 87:968-972.
61. Jameson, J., K. Ugarte, N. Chen, P. Yachi, E. Fuchs, R. Boismenu, and W. L. Havran. 2002. A role for skin γδ T cells in wound repair. Science 296:747-749.
62. Jameson, J., D. Witherden, and W. L. Havran. 2003. T-cell effector mechanisms: γδ and CD1d-restricted subsets. Curr. Opin. Immunol. 15:349-353.
63. Johnson, R. T. 1982. Viral infection of the nervous system. Lippincott-Raven Publishers, New York, N.Y.
64. Kandolf, R., A. Canu, and P. H. Hofschneider. 1985. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell. Cardiol. 17:167-181.
65. Kappos, L., G. Comi, H. Panitch, J. Oger, J. Antel, P. Conlon, and L. Steinman. 2000. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat. Med. 6:1176-1182.
66. + T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18: 593-603.
67. Kistner, A., M. Gossen, F. Zimmermann, J. Jerecic, C. Ullmer, H. Lubbert, and H. Bujard. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93:10933-10938.
68. Klingel, K., C. Hohenadl, A. Canu, M. Albrecht, M. Seemann, G. Mall, and R. Kandolf. 1992. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc. Natl. Acad. Sci. USA 89: 314-318.
69. Klingel, K., S. Stephan, M. Sauter, R. Zell, B. M. McManus, B. Bultmann, and R. Kandolf. 1996. Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J. Virol. 70:8888-8895.
70. Knowlton, K. U., E. S. Jeon, N. Berkley, R. Wessely, and S. Huber. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70:7811-7818.
71. Koezwara, K., E. Bonifacio, and A. G. Ziegler. 2004. Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 53:1-4.
72. Kuan, A. P., W. Chamberlain, S. Malkiel, H. D. Lieu, S. M. Factor, B. Diamond, and B. L. Kotzin. 1999. Genetic control of autoimmune myocarditis mediated by myosin-specific antibodies. Immunogenetics 49:79-85.
73. Kuhl, A. A., C. Loddenkemper, J. Westermann, and J. C. Hoffmann. 2002. Role of gamma delta T cells in inflammatory bowel disease. Pathobiology 70:150-155.
74. Kurts, C., W. R. Heath, F. R. Carhone, J. Allison, J. F. Miller, and H. Kosaka. 1996. Constitutive class 1-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923-930.
75. Kurtzke, J. F. 1997. The epidemiology of multiple sclerosis, p. 91-140. In C. S. Raine, H. F. McFarland, and W. W. Tourtellotte (ed.), Multiple sclerosis: clinical and pathogenetic basis. Chapman & Hall, London, England.
76. Kurtzke, J. F., G. Dean, and D. P. Botha. 1970. A method for estimating the age at immigration of white immigrants to South Africa, with an example of its importance. S. Afr. Med. J. 44:663-669.
77. Kurtzke, J. F., L. T. Kurland, and I. D. Goldberg. 1971. Mortality and migration in multiple sclerosis. Neurology 21:1186-1197.
78. Lake, R. S., D. C. Winkler, and E. H. Ludwig. 1970. Delay of mengovirus-induced cytopathology in mitotic L-cells. J. Virol. 5:262-263.
79. Lampert, P. W. 1978. Autoimmune and virus-induced demyelinating diseases. A review. Am. J. Pathol. 91:176-208.
80. Lang, K. S., M. Recher, T. Junt, A. A. Navarini, N. L. Harris, S. Freigang, B. Odermatt, C. Conrad, L. M. Ittner, S. Bauer, S. A. Luther, S. Uematsu, S. Akira, H. Hengartner, and R. M. Zinkernagel. 2005. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11:138-145.
81. Leifert, J. A., M. P. Rodriguez-Carreno, F. Rodriguez, and J. L. Whitton. 2004. Targeting plasmid-encoded proteins to the antigen presentation pathways. Immunol. Rev. 199:40-53.
82. Li, Y., T. Peng, Y. Yang, C. Niu, L. C. Archard, and H. Zhang. 2000. High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China. Heart 83:696-701.
83. 82a. Libbey, J. E., and R. S. Fujinami. 2003. Viral demyelinating disease in experimental animals, p. 125-133. In R. M. Herndon (ed.), Multiple sclerosis: immunology, pathology, and pathophysiology. Demos Medical Publishing, Inc., New York, N.Y.
84. Liu, P., K. Aitken, Y. Y. Kong, M. A. Opavsky, T. Martino, F. Dawood, W. H. Wen, I. Kozieradzki, K. Bachmaier, D. Straus, T. W. Mak, and J. M. Penninger. 2000. The tyrosine kinase p561ck is essential in coxsackievirus B3-mediated heart disease. Nat. Med. 6:429-434.
85. Lo, D., J. Freedman, S. Hesse, R. D. Palmiter, R. L. Brinster, and L. A. Sherman. 1992. Peripheral tolerance to an islet cell-specific hemagglutinin transgene affects both CD4+ and CD8+ T cells. Eur. J. Immunol. 22:1013-1022.
86. Luo, H., J. Zhang, F. Dastvan, B. Yanagawa, M. A. Reidy, H. M. Zhang, D. Yang, J. E. Wilson, and B. M. McManus. 2003. Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest. J. Virol. 77:1-9.
87. Mallucci, L., V. Wells, and D. Beare. 1985. Cell cycle position and expression of encephalomyocarditis virus in mouse embryo fibroblasts. J. Gen. Virol. 66:1501-1506.
88. Manolio, T. A., K. L. Baughman, R. Rodeheffer, T. A. Pearson, J. D. Bristow, V. V. Michels, W. H. Abelmann, and W. R. Harlan. 1992. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop. Am. J. Cardiol. 69: 1458-1466.
89. Marner, B., A. Lernmark, J., Ludvigsson, P. MacKay, I. Matsuba, J. Nerup, and A. Rabinovitch. 1985. Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis. Diabetes Res. 2:231-236.
90. Martin, R., B. Bielekova, B. Gran, and H. F. McFarland. 2000. Lessons from studies of antigen-specific T-cell responses in multiple sclerosis. J. Neural Transm. Suppl. 60:361-373.
91. Martino, T. A., P. Liu, M. Petric, and M. J. Sole. 1995. Enteroviral myocarditis and dilated cardiomyopathy: a review of clinical and experimental studies, p. 291-351. In H. A. Rotbart (ed.), Human enterovirus infections. ASM Press, Washington, D.C.
92. Matteucci, D., M. Paglianti, A. M. Giangregorio, M. R. Capobianchi, F. Dianzani, and M. Bendinelli. 1985. Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J. Virol. 56:651-654.
93. Mena, I., C. Fischer, J. R. Gebhard, C. M. Perry, S. Harkins, and J. L. Whitton. 2000. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276-288.
94. Mena, I., C. M. Perry, S. Harkins, F. Rodriguez, J. Gebhard, and J. L. Whitton. 1999. The role of B lymphocytes in coxsackievirus B3 infection. Am. J. Pathol. 155:1205-1215.
95. Mitrovic, B., L. J. Ignarro, S. Montestruque, A. Smoll, and J. E. Merrill. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575-585.
96. Mokhtarian, F., D. E. McFarlin, and C. S. Raine. 1984. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature 309:356-358.
97. Mukasa, A., W. K. Born, and R. L. O'Brien. 1999. Inflammation alone evokes the response of a TCR-invariant mouse gamma delta T-cell subset. J. Immunol. 162:4910-4913.
98. Mumford, C. J., N. W. Wood, H. Kellar-Wood, J. W. Thorpe, D. H. Miller, and D. A. Compston. 1994. The British Isles survey of multiple sclerosis in twins. Neurology 44:11-15.
99. Neu, N., S. W. Craig, N. R. Rose, F. Alvarez, and K. W. Beisel. 1987. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin. Exp. Immunol. 69:566-574.
100. Neu, N., R. Klieber, M. Fruhwirth, and P. Berger. 1991. Cardiac myosin-induced myocarditis as a model of postinfectious autoimmunity. Eur. Heart J. 12(Suppl. D):117-120.
101. Neu, N., C. Pummerer, T. Rieker, and P. Berger. 1993. T cells in cardiac myosin-induced myocarditis. Clin. Immunol. Immunopathol. 68:107-110.
102. O'Connell, J. B. 1987. The role of myocarditis in end-stage dilated cardiomyopathy. Tex. Heart Inst. J. 14:268-275.
103. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305-317.
104. Oldstone, M. B. A. 1988. Prevention of type 1 diabetes in nonobese diabetic mice by virus infection. Science 239:500-502.
105. Oldstone, M. B. A., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319-331.
106. Opavsky, M. A., T. Martino, M. Rabinovitch, J. Penninger, C. Richardson, M. Petric, C. Trinidad, L. Butcher, J. Chan, and P. P. Liu. 2002. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J. Clin. Investig. 109:1561-1569.
107. Op De Beeck, A., and P. Caillet-Fauquet. 1997. Viruses and the cell cycle. Prog. Cell Cycle Res. 3:1-19.
108. Pankuweit, S., I. Portig, F. Lottspeich, and B. Maisch. 1997. Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J. Mol. Cell. Cardiol. 29:77-84.
109. - T lymphocytes. J. Immunol. 127:1420-1423.
110. Pilipenko, E. V., T. V. Pestova, V. G. Kolupaeva, E. V. Khitrina, A. N. Poperechnaya, V. I. Agol, and C. U. T. Hellen. 2000. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev. 14:2028-2045.
111. Pummerer, C. L., K. Luze, G. Grassl, K. Bachmaier, F. Offner, S. K. Burrell, D. M. Lenz, T. J. Zamborelli, J. M. Penninger, and N. Neu. 1996. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J. Clin. Investig. 97:2057-2062.
112. Pyronnet, S., L. Pradayrol, and N. Sonenberg. 2000. A cell cycle-dependent internal ribosome entry site. Mol. Cell 5:607-616.
113. Rabinovitch, A., P. MacKay, J. Ludvigsson, and A. Lernmark. 1984. A prospective analysis of islet-cell cytotoxic antibodies in insulin-dependent diabetic children. Transient effects of plasmapheresis. Diabetes 33:224-228.
114. Richert, J. R., B. F. Driscoll, M. W. Kies, and E. C. Alvord, Jr. 1979. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen. J. Immunol. 122:494-496.
115. Richert, J. R., T. J. Lehky, L. A. Muehl, E. S. Mingioli, and D. E. McFarlin. 1985. Myelin basic protein-specific T-cell lines and clones derived from SJL/J mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 8:129-139.
116. Riecansky, I., Z. Schreinerova, A. Egnerova, A. Petrovicova, and O. Bzduchova. 1989. Incidence of Coxsackie virus infection in patients with dilated cardiomyopathy. Cor Vasa 31:225-230.
117. Sadovnick, A. D., H. Armstrong, G. P. A. Rice, D. Bulman, L. Hashimoto, D. W. Paty, S. A. Hashimoto, S. Warren, W. Hader, and T. J. Murray. 1993. A population-based study of multiple sclerosis in twins: update. Ann. Neurol. 33:281-285.
118. Schubert, C. 2004. The worm has turned. Nat. Med. 10:1271-1272.
119. Seewaldt, S., H. E. Thomas, M. Ejrnaes, U. Christen, T. Wolfe, E. Rodrigo, B. Coon, B. Michelsen, T. W. H. Kay, and M. G. von Herrath. 2000. Virus-induced autoimmune diabetes: Most β-cells die through inflammatory cytokines and not perform from autoreactive (anti-viral) cytotoxic T-lymphocytes. Diabetes 49:1801-1809.
120. Selin, L. K., M. Cornberg, M. A. Brehm, S. K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, and R. M. Welsh. 2004. CD8 memory T cells: cross-reactivity and heterologous immunity. Semin. Immunol. 16:335-347.
121. Serreze, D. V., E. W. Ottendorfer, T. M. Ellis, C. J. Gauntt, and M. A. Atkinson. 2000. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T cells in pancreatic islets. Diabetes 49:708-711.
122. Sevilla, N., D. Homann, M. G. von Herrath, F. Rodriguez, S. Harkins, J. L. Whitton, and M. B. A. Oldstone. 2000. Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease. J. Virol. 74:3284-3292.
123. + T cells during picornavirus infection. J. Virol. 75:2377-2387.
124. Smyth, M. J., and J. D. Sedgwick. 1998. Delayed kinetics of tumor necrosis factor-mediated bystander lysis by peptide-specific CD8+ cytotoxic T lymphocytes. Eur. J. Immunol. 28:4162-4169.
125. Sole, M. J., and P. Liu. 1993. Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J. Am. Coll. Cardiol. 22:99A-105A.
126. Srinivasappa, J., J. Saegusa, B. S. Prabbakar, M. K. Gentry, M. J. Buchmeier, T. J. Wiktor, H. Koprowski, M. B. Oldstone, and A. L. Notkins. 1986. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J. Virol. 57:397-401.
127. Suarez, M., G. Contreras, and B. Fridlender. 1975. Multiplication of coxsackie B1 virus in synchronized HeLa cells. J. Virol. 16:1337-1339.
128. Sundkvist, G., W. A. Hagopian, M. Landin-Olsson, A. Lernmark, L. Ohlsson, C. Ericsson, and J. Ahlmen. 1994. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 78:1159-1165.
129. Sutton, G. C., H. B. Harding, R. P. Trueheart, and H. P. Clark. 1967. Coxsackie B4 myocarditis in an adult: successful isolation of virus from ventrieular myocardium. Clin. Aviation Aerospace Med. 38:66-69.
130. Sutton, G. C., J. R. Tobin, R. T. Fox, R. J. Freeark, and J. F. Driscoll. 1963. Study of the pericardium and ventricular myocardium. Exploratory mediastinotomy and biopsy in unexplained heart disease. JAMA 185:786-788.
131. Swanborg, R. H. 1983. Autoimmune effector cells. V. A monoclonal antibody specific for rat helper T lymphocytes inhibits adoptive transfer of autoimmune encephalomyelitis. J. Immunol. 130:1503-1505.
132. Swanton, C., and N. Jones. 2001. Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int. J. Exp. Pathol. 82:3-13.
133. Tam, P. E., D. R. Fontana, and R. P. Messner. 2003. Coxsackievirus B1-induced chronic inflammatory myopathy: differences in induction of autoantibodies to muscle and nuclear antigens by cloned myopathic and amyopathic viruses. J. Lab Clin. Med. 142:196-204.
134. Tam, P. E., and R. P. Messner. 1999. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J. Virol. 73:10113-10121.
135. Tam, P. E., A. M. Schmidt, S. R. Ytterberg, and R. P. Messner. 1991. Viral persistence during the developmental phase of coxsackievirus B1-induced murine polymyositis. J. Virol. 65:6654-6660.
136. Tam, P. E., A. M. Schmidt, S. R. Ytterberg, and R. P. Messner. 1994. Duration of virus persistence and its relationship to inflammation in the chronic phase of coxsackievirus B1-induced murine polymyositis. J. Lab. Clin. Med. 123:346-356.
137. Theil, D. J., I. Tsunoda, F. Rodriguez, J. L. Whitton, and R. S. Fujinami. 2001. Viruses can silently prime for and trigger central nervous system autoimmune disease. J. Neurovirol. 7:220-227.
138. Tsunoda, I., and R. S. Fujinami. 1996. Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55:673-680.
139. + cytotoxic cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity. J. Virol. 76:12834-12844.
140. Vanderlugt, C. J., and S. D. Miller. 1996. Epitope spreading. Curr. Opin. Immunol. 8:831-836.
141. Venkatesan, A., R. Sharma, and A. Dasgupta. 2003. Cell cycle regulation of hepatitis C and encephalomyocarditis virus internal ribosome entry site-mediated translation in human embryonic kidney 293 cells. Virus Res. 94:85-95.
142. von Herrath, M., and J. F. Bach. 2002. Juvenile autoimmune diabetes: a pathogenic role for maternal antibodies? Nat. Med. 8:331-333.
143. von Herrath, M. G., J. Dockter, and M. B. A. Oldstone. 1994. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231-242.
144. von Herrath, M. G., R. S. Fujinami, and J. L. Whitton. 2003. Microorganisms and autoimmunity: making the barren field fertile? Nat. Rev. Microbiol. 1:151-157.
145. von Herrath. M. G., and M. B. A. Oldstone. 1997. Interferon-γ is essential for destruction of b cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:531-539.
146. Ward, C. 1978. Severe arrhythmias in Coxsackievirus B3 myopericarditis. Arch. Dis. Child. 53:174-176.
147. Welsh, R. M., and L. K. Selin. 2002. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2:417-426.
148. Werner, P., D. Pitt, and C. S. Raine. 2001. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann. Neurol. 50:169-180.
149. Wessely, R., A. Henke, R. Zell, R. Kandolf. and K. U. Knowlton. 1998. Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation 98:450-457.
150. Wesselty, R., K. Klingel, L. F. Santana, N. Dalton. M. Hongo, L. W. Jonathan, R. Kandolf, and K. U. Knowlton. 1998. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J. Clin. Investig. 102:1444-1453.
151. Wilson, N. S., and J. A. Villadangos. 2005. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 86:241-305.
152. Wolfgram, L. J., K. W. Beisel, A. Herskowitz, and N. R. Rose. 1986. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J. Immunol. 136:1846-1852.
153. Wolfgram, L. J., K. W. Beisel, and N. R. Rose. 1985. Heart-specific auto-antibodies following murine coxsackievirus B3 myocarditis. J. Exp. Med. 161:1112-1121.
154. Woodruff, J. F. 1980. Viral myocarditis. A review. Am. J. Pathol. 101:425-484.
155. Woodruff, J. F., and J. J. Woodruff. 1974. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J. Immunol. 113:1726-1734.
156. Wucherpfennig, K. W., and J. L. Strominger. 1995. Molecular mimicry in T-cell-mediated autoimmunity: Viral peptidcs activate human T-cell clones specific for myelin basic protein. Cell 80:695-705.
157. Yasukawa, M., Y. Yakushijin, H. Hasegawa, M. Miyake, Y. Hitsumoto, S. Kitmura, N. Takeuchi, and S. Fujita. 1993. Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factor-beta) in virus-specific CD4+ human cytoloxic T-cell clones. Blood 81:1527-1534.
158. Yiyun, C., S. Yagi, and D. Schnurr. 1989. Persistent infections by coxsackic virus B3, p. 105-112. In F. Auti (ed.), Pathogenesis and control of viral infections. Raven Press, New York, N.Y.
159. Zabriskie, J. B. 1982. Rheumatic fever: a streptococcal-induced autoimmune disease? Pediatr. Ann. 11:383-396.
160. Zamvil, S. S., D. J. Mitchell, A. C. Moore, A. J. Schwarz, W. Stiefel, P. A. Nelson, J. B. Rothbard, and L. Steinman. 1987. T-cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein. J. Immunol. 139:1075-1079.
161. Zipris, D., E. Lien, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini. 2005. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J. Immunol. 174:131-142.